Essex Investment Management Co. LLC cut its stake in Aterian, Inc. (NASDAQ:ATER – Free Report) by 19.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 28,385 shares of the company’s stock after selling 7,068 shares during the quarter. Essex Investment Management Co. LLC’s holdings in Aterian were worth $68,000 at the end of the most recent reporting period.
Separately, Jane Street Group LLC acquired a new position in shares of Aterian in the 3rd quarter worth approximately $33,000. 7.02% of the stock is currently owned by institutional investors and hedge funds.
Aterian Price Performance
ATER stock opened at $2.06 on Tuesday. The business has a fifty day moving average price of $2.23 and a 200 day moving average price of $2.60. Aterian, Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $6.42. The stock has a market capitalization of $18.04 million, a price-to-earnings ratio of -0.75 and a beta of 2.03.
Aterian Company Profile
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
Read More
- Five stocks we like better than Aterian
- What is a Bond Market Holiday? How to Invest and Trade
- How to Protect Your Portfolio When Inflation Is Rising
- 3 Stocks to Consider Buying in October
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Insider Buying Explained: What Investors Need to Know
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding ATER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aterian, Inc. (NASDAQ:ATER – Free Report).
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.